AssetMark Inc’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-639
| Closed | -$32K | – | 1542 |
|
|
2021
Q3 | $32K | Hold |
639
| – | – | ﹤0.01% | 861 |
|
|
2021
Q2 | $40K | Sell |
639
-449
| -41% | -$28.1K | ﹤0.01% | 785 |
|
|
2021
Q1 | $101K | Buy |
1,088
+408
| +60% | +$37.9K | ﹤0.01% | 628 |
|
|
2020
Q4 | $61K | Sell |
680
-6
| -0.9% | -$538 | ﹤0.01% | 678 |
|
|
2020
Q3 | $71K | Buy |
686
+268
| +64% | +$27.7K | ﹤0.01% | 626 |
|
|
2020
Q2 | $33K | Buy |
+418
| New | +$33K | ﹤0.01% | 716 |
|
|
2019
Q3 | – | Sell |
-143
| Closed | -$7K | – | 1328 |
|
|
2019
Q2 | $7K | Buy |
143
+33
| +30% | +$1.62K | ﹤0.01% | 1010 |
|
|
2019
Q1 | $6K | Buy |
110
+19
| +21% | +$1.04K | ﹤0.01% | 1042 |
|
|
2018
Q4 | $5K | Sell |
91
-61
| -40% | -$3.35K | ﹤0.01% | 1090 |
|
|
2018
Q3 | $10K | Sell |
152
-14
| -8% | -$921 | ﹤0.01% | 1045 |
|
|
2018
Q2 | $8K | Sell |
166
-9
| -5% | -$434 | ﹤0.01% | 1080 |
|
|
2018
Q1 | $9K | Buy |
175
+6
| +4% | +$309 | ﹤0.01% | 1063 |
|
|
2017
Q4 | $8K | Buy |
169
+167
| +8,350% | +$7.91K | ﹤0.01% | 1151 |
|
|
2017
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1497 |
|
|
2017
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1392 |
|
|
2017
Q1 | $0 | Sell |
2
-14
| -88% | – | ﹤0.01% | 1304 |
|
|
2016
Q4 | $1K | Buy |
16
+14
| +700% | +$875 | ﹤0.01% | 1183 |
|
|
2016
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1222 |
|
|
2016
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1193 |
|
|
2016
Q1 | $0 | Sell |
2
-7,335
| -100% | – | ﹤0.01% | 1229 |
|
|
2015
Q4 | $294K | Sell |
7,337
-278
| -4% | -$11.1K | 0.01% | 387 |
|
|
2015
Q3 | $217K | Sell |
7,615
-3,285
| -30% | -$93.6K | ﹤0.01% | 326 |
|
|
2015
Q2 | $359K | Sell |
10,900
-899
| -8% | -$29.6K | 0.01% | 389 |
|
|
2015
Q1 | $339K | Buy |
+11,799
| New | +$339K | 0.01% | 377 |
|